Guided Therapeutics Inc (GTHP.OB)
GTHP.OB on OTC BB
0.69USD
3:20pm EDT
0.69USD
3:20pm EDT
Price Change (% chg)
$0.00 (+0.15%)
$0.00 (+0.15%)
Prev Close
$0.69
$0.69
Open
$0.69
$0.69
Day's High
$0.69
$0.69
Day's Low
$0.69
$0.69
Volume
10,900
10,900
Avg. Vol
111,244
111,244
52-wk High
$0.98
$0.98
52-wk Low
$0.52
$0.52
About
Guided Therapeutics, Inc., formerly SpectRx, Inc., is a medical technology company focused on developing medical devices. Its primary focus is the development of its cervical cancer detection technology (LightTouch) and extension of its cancer detection platform into other cancers, especially lung and esophageal. Its technology,... (more)
No analyst recommendations are available for GTHP.OB.
Overall
| Beta: | -0.40 |
| Market Cap (Mil.): | $45.12 |
| Shares Outstanding (Mil.): | 65.49 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| GTHP.OB | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 66.39 | 37.76 |
| EPS (TTM): | -0.09 | -- | -- |
| ROI: | -361.88 | 4.99 | 18.76 |
| ROE: | -386.72 | 9.80 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Merck & Co., Inc. (MRK.N) | $48.58 | +0.41 |
| GlaxoSmithKline plc (GSK.L) | 1,712.50p | +28.50 |
| Hologic, Inc. (HOLX.OQ) | $22.86 | +0.16 |
| Qiagen NV (QGEN.DE) | €16.10 | +0.56 |
| SpectraScience, Inc. (SCIE.PK) | $0.05 | -- |
Earnings vs.
Estimates
No consensus analysis data available.
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: TheStreet.com Ratings
|
$10.00
|
|
Provider: GlobalData
|
$250.00
|
|
Provider: Plunkett Research, Ltd.
|
$99.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

